ZhuZhou QianJin Pharmaceutical Co Ltd (600479) — Capital Reinvestment Ratio
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥288.83 Million) in capital expenditures (CN¥23.89 Million). See 600479 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ZhuZhou QianJin Pharmaceutical Co Ltd Capital Reinvestment Ratio (2002–2025)
This chart tracks ZhuZhou QianJin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 24 annual periods. Check ZhuZhou QianJin Pharmaceutical Co Ltd (600479) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2025)
Year-by-year Capital Reinvestment Ratio for ZhuZhou QianJin Pharmaceutical Co Ltd from 2002 to 2025. For live market cap and broader valuation context, see market cap of ZhuZhou QianJin Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | CN¥480.24 Million | CN¥124.17 Million | ▲ +117.9% |
| 2024 | 0.12x | CN¥398.77 Million | CN¥47.32 Million | ▲ +19.5% |
| 2023 | 0.10x | CN¥443.12 Million | CN¥43.99 Million | ▲ +111.5% |
| 2022 | 0.05x | CN¥733.47 Million | CN¥34.43 Million | ▼ -68.3% |
| 2021 | 0.15x | CN¥485.57 Million | CN¥71.88 Million | ▼ -17.4% |
| 2020 | 0.18x | CN¥542.37 Million | CN¥97.24 Million | ▼ -31.4% |
| 2019 | 0.26x | CN¥155.49 Million | CN¥40.61 Million | ▲ +115.9% |
| 2018 | 0.12x | CN¥383.47 Million | CN¥46.39 Million | ▼ -40.2% |
| 2017 | 0.20x | CN¥283.47 Million | CN¥57.30 Million | ▼ -65.1% |
| 2016 | 0.58x | CN¥140.88 Million | CN¥81.50 Million | ▼ -53.8% |
| 2015 | 1.25x | CN¥67.48 Million | CN¥84.47 Million | ▲ +247.9% |
| 2014 | 0.36x | CN¥183.34 Million | CN¥65.97 Million | ▼ -41.2% |
| 2013 | 0.61x | CN¥137.63 Million | CN¥84.26 Million | ▼ -52.7% |
| 2012 | 1.30x | CN¥197.82 Million | CN¥256.26 Million | ▼ -54.2% |
| 2011 | 2.83x | CN¥22.58 Million | CN¥63.87 Million | ▲ +89.4% |
| 2010 | 1.49x | CN¥39.13 Million | CN¥58.44 Million | ▼ -10.9% |
| 2009 | 1.68x | CN¥73.54 Million | CN¥123.31 Million | ▼ -34.5% |
| 2008 | 2.56x | CN¥37.20 Million | CN¥95.30 Million | ▲ +801.0% |
| 2007 | 0.28x | CN¥79.26 Million | CN¥22.53 Million | ▲ +59.7% |
| 2006 | 0.18x | CN¥120.12 Million | CN¥21.39 Million | ▼ -18.6% |
| 2005 | 0.22x | CN¥76.50 Million | CN¥16.74 Million | ▼ -92.9% |
| 2004 | 3.06x | CN¥18.45 Million | CN¥56.50 Million | ▲ +358.2% |
| 2003 | 0.67x | CN¥50.96 Million | CN¥34.05 Million | ▼ -93.1% |
| 2002 | 9.75x | CN¥6.07 Million | CN¥59.24 Million | — |